Timing of renal replacement therapy in critically ill patients with acute kidney injury

Current Opinion in Critical Care

Volumn 13, Issue 6, 2007, Pages 656-661

  Bouman, Catherine S C ^a   Oudemans Van Straaten, Heleen M ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

Author keywords

Acute kidney injury; Acute renal failure; Biomarkers; Multiple organ failure; Renal replacement therapy; Timing

Indexed keywords

BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; CLINICAL TRIAL; CONTINUOUS HEMODIAFILTRATION; CONTROLLED CLINICAL TRIAL; CONVALESCENCE; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; HUMAN; KIDNEY DYSFUNCTION; MULTIPLE ORGAN FAILURE; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; REVIEW; SHOCK; TIME; TIME TO TREATMENT; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

ACUTE DISEASE; BIOLOGICAL MARKERS; CRITICAL ILLNESS; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; RENAL REPLACEMENT THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 35848961191     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3282f0eae2     Document Type: Review

References (51)

1. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294:813-818.
2. Metnitz PG, Krenn CG, Steltzer H, et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002; 30:2051-2058.
3. Chertow GM, Levy EM, Hammermeister KE, et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998; 104:343-348.
4. de Mendonca A, Vincent JL, Suter PM, et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000; 26:915-921.
5. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996; 275:1489-1494.
6. Ricci Z, Ronco C, D'Amico G, et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant 2006; 21:690-696. Survey on the responses of 560 contributors to a questionnaire submitted during an international course on critical care nephrology concerning practice patterns in the management of ARF, including RRT.
7. Uchino S, Bellomo R, Morimatsu H, et al. Continuous renal replacement therapy: a worldwide practice survey: the Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. Intensive Care Med 2007; 27 June [Epub ahead of print]. The largest prospective multicenter study on continuous RRT practice patterns in 23 countries.
8. Bouman CS, Oudemans-van Straaten HM, Tijssen JG, et al. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 2002; 30:2205-2211.
9. Kellum JA, Angus DC, Johnson JP, et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 2002; 28:29-37.
10. Mehta RL, McDonald B, Gabbai FB, et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001; 60:1154-1163.
11. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356:26-30.
12. Saudan P, Niederberger M, De Seigneux S, et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006; 70:1312-1317.
13. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346:305-310.
14. Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002; 40:875-885.
15. Vinsonneau C, Camus C, Combes A, et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006; 368:379-385.
16. Bellomo R. Augmented versus normal renal replacement therapy in severe acute renal failure. http://www.clinicaltrials.gov/ct/show/NCT00221013?order=3. [Accessed June 2007]
17. Joannes-Boyau O. The IVOIRE study. http://www.clinicaltrials.gov/ct/show/ NCT00241228?order=1. [Accessed June 2007]
18. Palevsky PM, O'Connor T, Zhang JH, et al. Design of the VA/NIH Acute Renal Failure Trial Network (ATN) Study: intensive versus conventional renal support in acute renal failure. Clin Trials 2005; 2:423-435.
19. Schwenger V. Comparison of dialysis strategies in critically ill patients with acute renal failure. http://www.clinicaltrials.gov/ct/show/NCT00322530? order=1. [Accessed June 2007]
20. Augustine JJ, Sandy D, Seifert TH, Paganini EP. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 2004; 44:1000-1007.
21. Gasparovic V, Filipovic-Grcic I, Merkler M, Pisl Z. Continuous renal replacement therapy (CRRT) or intermittent hemodialysis (IHD): what is the procedure of choice in critically ill patients? Ren Fail 2003; 25:855-862.
22. Uehlinger DE, Jakob SM, Ferrari P, et al. Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 2005; 20:1630-1637.
23. Bellomo R, Ronco C. Indications and criteria for initiating renal replacement therapy in the intensive care unit. Kidney Int Suppl 1998; 66:S106-S109.
24. Kellum JA, Mehta RL, Angus DC, et al. The first international consensus conference on continuous renal replacement therapy. Kidney Int 2002; 62:1855-1863.
25. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ. Acute renal failure in intensive care units: causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med 1996; 24:192-198.
26. Cole L, Bellomo R, Silvester W, Reeves JH. A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a 'closed' ICU system. Am J Respir Crit Care Med 2000; 162:191-196.
27. Himmelfarb J, Tolkoff RN, Chandran P, et al. A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. J Am Soc Nephrol 1998; 9:257-266.
28. Jiang HL, Xue WJ, Li DQ, et al. Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis. World J Gastroenterol 2005; 11:4815-4821.
29. Demirkilic U, Kuralay E, Yenicesu M, et al. Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg 2004; 19:17-20.
30. Elahi MM, Lim MY, Joseph RN, et al. Early hemofiltration improves survival in postcardiotomy patients with acute renal failure. Eur J Cardiothorac Surg 2004; 26:1027-1031.
31. Gettings LG, Reynolds HN, Scalea T. Outcome in posttraumatic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med 1999; 25:805-813.
32. Piccinni P, Dan M, Barbacini S, et al. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 2006; 32:80-86.
33. Bouman CSC, Oudemans-van Straaten HM. Guidelines for timing, dose and mode of continuous renal replacement therapy for acute renal failure in the critically ill. Neth J Crit Care 2006; 10:561-568.
34. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212.
35. Kellum JA, Levin N, Bouman C, Lameire N. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 2002; 8:509-514.
36. Bell M, Liljestam E, Granath F, et al. Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria. Nephrol Dial Transplant 2005; 20:354-360.
37. Hoste EA, Kellum JA. Acute kidney injury: epidemiology and diagnostic criteria. Curr Opin Crit Care 2006; 12:531-537.
38. Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettila V. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg 2006; 81:542-546.
39. Lopes JA, Jorge S, Silva S, et al. An assessment of the RIFLE criteria for acute renal failure following myeloablative autologous and allogeneic haematopoietic cell transplantation. Bone Marrow Transplant 2006; 38:395.
40. O'Riordan A, Wong V, McQuillan R, et al. Acute renal disease, as defined by the RIFLE criteria, postliver transplantation. Am J Transplant 2007; 7:168-176.
41. Uchino S, Bellomo R, Goldsmith D, et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006; 34:1913-1917. Large retrospective single center study assessing the RIFLE criteria and showing that 20% of the hospitalized patients had some degree of acute impairment in renal function and that the RIFLE criteria were useful in predicting hospital mortality.
42. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31. The first paper introducing the slightly modified RIFLE criteria for staging of AKI.
43. Bouman CS, Oudemans-van Straaten HM, Schultz MJ, Vroom MB. Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing. J Crit Care 2007; 22:1-12. Descriptive analysis of animal and human studies determining the role of ultra-filtration dose and timing on the physiological and clinical effects of hemofiltration in sepsis and systemic inflammatory response syndrome.
44. Cornejo R, Downey P, Castro R, et al. High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 2006; 32:713-722.
45. Honore PM, Jamez J, Wauthier M, et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000; 28:3581-3587.
46. Page B, Vieillard-Baron A, Chergui K, et al. Early veno-venous haemodiafiltration for sepsis-related multiple organ failure. Crit Care 2005; 9:R755-R763.
47. Vanholder R, Schepers E, Meert N, Lameire N. What is uremia? Retention versus oxidation. Blood Purif 2006; 24:33-38.
48. Himmelfarb J, McMonagle E, Freedman S, et al. Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 2004; 15:2449-2456.
49. Trof RJ, Di Maggio F, Leemreis J, Groeneveld AB. Biomarkers of acute renal injury and renal failure. Shock 2006; 26:245-253. Review of human and animal studies on the various biomarkers for AKI.
50. Bagshaw SM, Langenberg C, Haase M, et al. Urinary biomarkers in septic acute kidney injury. Intensive Care Med 2007; 33:1285-1296. Appraisal of the literature on the value of urinary biomarkers in septic AKI.
51. Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66:1115-1122.